84 related articles for article (PubMed ID: 28209473)
1. Analysis of Peripheral T-cell Lymphoma Diagnostic Workup in the United States.
Hsi ED; Horwitz SM; Carson KR; Pinter-Brown LC; Rosen ST; Pro B; Federico M; Gisselbrecht C; Schwartz M; Bellm LA; Acosta M; Collie AM; Gruver AM; Grzywacz BJ; Turakhia S; Shustov AR; Advani RH; Feldman T; Lechowicz MJ; Smith SM; Lansigan F; Tulpule A; Craig MD; Greer JP; Kahl BS; Leach JW; Morganstein N; Casulo C; Park SI; Foss FM
Clin Lymphoma Myeloma Leuk; 2017 Apr; 17(4):193-200. PubMed ID: 28209473
[TBL] [Abstract][Full Text] [Related]
2. Peripheral T-cell lymphomas expressing CD30 and CD15 expand the spectrum of anaplastic large cell lymphoma, ALK-negative.
Ganapathi KA; Nicolae A; Egan C; Geng H; Xi L; Pack SD; McFadden JR; Raffeld M; Jaffe ES; Pittaluga S
Br J Haematol; 2024 May; 204(5):1862-1871. PubMed ID: 38613165
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological implications of immunohistochemical expression of TBX21, CXCR3, GATA3, CCR4, and TCF1 in nodal follicular helper T-cell lymphoma and peripheral T-cell lymphoma, not otherwise specified.
Han B; Lim S; Yim J; Song YK; Koh J; Kim S; Lee C; Kim YA; Jeon YK
J Pathol Transl Med; 2024 Mar; 58(2):59-71. PubMed ID: 38247153
[TBL] [Abstract][Full Text] [Related]
4. Outcome of combined modality treatment in first-line for stage I(E) peripheral T-cell lymphoma; a nationwide population-based cohort study from the Netherlands.
Meeuwes FO; Brink M; Plattel W; Van der Poel MWM; Kersten MJ; Wondergem M; Böhmer L; Woei-A-Jin FJSH; Visser O; Oostvogels R; Jansen PM; Neelis KJ; Crijns APG; Daniëls LA; Snijders TJF; Vermaat JSP; Huls GA; Nijland M
Haematologica; 2024 Apr; 109(4):1163-1170. PubMed ID: 37794805
[TBL] [Abstract][Full Text] [Related]
5. Clonal haematopoiesis: A common progenitor for cytotoxic peripheral T-cell lymphoma and angioimmunoblastic T-cell lymphoma.
Vogelsberg A; Harland L; Borgmann V; Otto F; Weller JF; Nann D; Quintanilla-Martinez L; Fend F
Br J Haematol; 2024 May; 204(5):2071-2076. PubMed ID: 38323682
[TBL] [Abstract][Full Text] [Related]
6. Peripheral T-cell lymphoma: Are all patients high-risk?
Shea L; Mehta-Shah N
Blood; 2023 Dec; ():. PubMed ID: 38142400
[TBL] [Abstract][Full Text] [Related]
7. The gene expression profile and cell of origin of canine peripheral T-cell lymphoma.
Owens E; Harris L; Harris A; Yoshimoto J; Burnett R; Avery A
BMC Cancer; 2024 Jan; 24(1):18. PubMed ID: 38166662
[TBL] [Abstract][Full Text] [Related]
8. Impact of primary organ site of involvement by peripheral T-cell lymphoma not otherwise specified on survival.
Davis O; Truong D; Day S; Pandey M; Ibrahimi S; Khawandanah M; Holter-Chakrabarty J; Asch A; Al-Juhaishi T
Cancer Med; 2023 Dec; 12(24):21770-21778. PubMed ID: 38073461
[TBL] [Abstract][Full Text] [Related]
9. Incidence trends for common subtypes of T-cell lymphoma in Taiwan and the United States from 2008-2020.
Huang CI; Ker CY; Li HJ; Hsiao YT; Lin SF; Su YC
Int J Hematol; 2024 Mar; ():. PubMed ID: 38494548
[TBL] [Abstract][Full Text] [Related]
10.
Moon CS; Reglero C; Cortes JR; Quinn SA; Alvarez S; Zhao J; Lin WW; Cooke AJ; Abate F; Soderquist CR; Fiñana C; Inghirami G; Campo E; Bhagat G; Rabadan R; Palomero T; Ferrando AA
Nat Cancer; 2021 Jan; 2(1):98-113. PubMed ID: 33928261
[TBL] [Abstract][Full Text] [Related]
11. Current and upcoming treatment approaches to common subtypes of PTCL (PTCL NOS, ALCL, TFHs).
Moskowitz AJ; Stuver RN; Horwitz SM
Blood; 2024 Feb; ():. PubMed ID: 38306597
[TBL] [Abstract][Full Text] [Related]
12. Unraveling the mystery of fever of unknown origin: a remarkable journey towards the diagnosis of peripheral T-cell lymphoma-T follicular helper type: A rare case report.
Trifonov PI; Koltchakov VK; Mihaylova-Garnizova RP; Yordanov AY; Sokolova L; Nikolov RK; Krastev ZA
Medicine (Baltimore); 2024 Jan; 103(3):e36974. PubMed ID: 38241538
[TBL] [Abstract][Full Text] [Related]
13. Myositis as a prominent manifestation of primary skeletal muscle peripheral T-cell lymphoma: a case report and literature review.
Jin Z; Hu J; Min T; Chen L; Zhang F; Kong R; Gao J
Clin Rheumatol; 2024 May; ():. PubMed ID: 38748302
[TBL] [Abstract][Full Text] [Related]
14. Overlap between EBV-positive diffuse large B-cell lymphoma, NOS, in a young patient and angioimmunoblastic T-cell lymphoma: A diagnostic pitfall.
Kim CH; Ghaffaripour T; Zhou Y; Chapman JR
Clin Case Rep; 2021 Mar; 9(3):1371-1375. PubMed ID: 33768847
[TBL] [Abstract][Full Text] [Related]
15. A novel case of peripheral T-cell lymphoma, not otherwise specified, with rhabdoid morphology and INI1 loss.
Saksena A; Rajgariah A
Blood; 2023 Aug; 142(7):675. PubMed ID: 37590025
[No Abstract] [Full Text] [Related]
16. How molecular advances may improve the diagnosis and management of PTCL patients.
Drieux F; Lemonnier F; Gaulard P
Front Oncol; 2023; 13():1202964. PubMed ID: 37427095
[TBL] [Abstract][Full Text] [Related]
17. The diagnosis and management of suspected lymphoma in general practice.
Paquin AR; Oyogoa E; McMurry HS; Kartika T; West M; Shatzel JJ
Eur J Haematol; 2023 Jan; 110(1):3-13. PubMed ID: 36093749
[TBL] [Abstract][Full Text] [Related]
18. Management of Peripheral T-cell Lymphomas and the Role of Transplant.
Foley NC; Mehta-Shah N
Curr Oncol Rep; 2022 Nov; 24(11):1489-1499. PubMed ID: 35947286
[TBL] [Abstract][Full Text] [Related]
19. Recent Advances in the Management of Relapsed and Refractory Peripheral T-Cell Lymphomas.
Braunstein Z; Ruiz M; Hanel W; Shindiapina P; Reneau JC; Brammer JE
J Pers Med; 2022 Jun; 12(6):. PubMed ID: 35743749
[TBL] [Abstract][Full Text] [Related]
20. DNMT3A mutations define a unique biological and prognostic subgroup associated with cytotoxic T cells in PTCL-NOS.
Herek TA; Bouska A; Lone W; Sharma S; Amador C; Heavican TB; Li Y; Wei Q; Jochum D; Greiner TC; Smith L; Pileri S; Feldman AL; Rosenwald A; Ott G; Lim ST; Ong CK; Song J; Jaffe ES; Wang GG; Staudt L; Rimsza LM; Vose J; d'Amore F; Weisenburger DD; Chan WC; Iqbal J
Blood; 2022 Sep; 140(11):1278-1290. PubMed ID: 35639959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
